Apollon Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.04M | Buy |
|
|||||
|
2025
Q2 | $3.21M | Sell |
|
|||||
|
2025
Q1 | $3.42M | Buy |
|
|||||
|
2024
Q4 | $3.8M | Buy |
|
|||||
|
2024
Q3 | $4.62M | Buy |
|
|||||
|
2024
Q2 | $5.41M | Sell |
|
|||||
|
2024
Q1 | $4.95M | Sell |
|
|||||
|
2023
Q4 | $4.26M | Buy |
|
|||||
|
2023
Q3 | $1.45M | Buy |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $1.03M | Sell |
|
|||||
|
2022
Q4 | $912K | Sell |
|
|||||
|
2022
Q3 | $688K | Buy |
|
|||||
|
2022
Q2 | $654K | Buy |
|
|||||
|
2022
Q1 | $592K | Buy |
|
|||||
|
2021
Q4 | $417K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $953K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2K | Buy |
|